Recurly vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 81)

Recurly

LeaderSubscription Services

General

San Francisco subscription billing platform at $15B annual payment volume/100M+ subscribers; $1.3B revenue recovered in 2024 with Prive/Redfast acquisitions and Compass AI suite; $39.2M raised with CEO Rohrlich competing with Chargebee for digital media billing.

AI VisibilityBeta
Overall Score
A81
Category Rank
#23 of 1167
AI Consensus
61%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
73
Gemini
91

About

Recurly is a San Francisco, California-based subscription billing and revenue management platform — backed with $39.2 million in total funding — providing digital media, streaming, SaaS, publishing, education, and consumer goods companies including Sling, Twitch, BarkBox, FabFitFun, Paramount, Lucid, and Sprout Social with subscription lifecycle management that processes $15 billion in annual payment volume across 100 million+ active subscribers and recovered $1.3 billion in customer revenues through payment retry and dunning tools in 2024. In 2024, Recurly appointed Joe Rohrlich (formerly CEO of Top Hat and Chief Revenue Officer at Bazaarvoice) as CEO for the next growth phase, and acquired Prive (Shopify-first subscription management) and Redfast (subscriber engagement and retention tools) to create the first subscription management suite integrating billing, payments, analytics, real-time engagement, and e-commerce subscriptions. Recurly Compass (AI-driven analytics and insights suite) launched in 2024. Founded September 2009 by Isaac Hall, Dan Burkhart, and Tim Van Loan.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

81
Overall Score
90
#23
Category Rank
#9
61
AI Consensus
60
stable
Trend
stable
84
ChatGPT
99
73
Perplexity
99
91
Gemini
83
84
Claude
96
82
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.